Advertisement
"Today's generation of financial professionals access and act oninformation in a whole new way," said Devin Wenig, CEO, Thomson ReutersMarkets. "Reuters Insider was built to give our clients a competitiveadvantage and arm them with the multimedia tools needed to work faster andsmarter."
Advertisement
"As a content partner with Reuters Insider, this is a match made inheaven", said Doug Cookson, Commercial Director, PharmaVentures."PharmaTelevision provides a unique service for the biopharmaceuticalindustry providing daily television news, analysis and feature interviewswith industry leaders and the relationship with Reuters Insider now allowsthe Financial Communities around the world to have easy access to thiscontent"
Anne Vindenes Allen, Managing Director, PharmaTelevision added. "Thisexciting relationship is now providing a clear channel for theBiopharmaceutical Industry to provide insight, particularly through ourFinancial Reports, in an impactful manner, to potentially hundreds ofthousands of critical stakeholders in the financial sector"
PharmaTelevision is produced by professional television industry expertsusing professional studios worldwide as well as its own studios in the UK.
PharmaTelevision produces Open Content as well as subscription basedPremium Content.
PharmaTelevision Open Content includes the Regional Report - a programmethat focuses on the key locations for pharmaceutical and biotech investment,the Financial Report - a programme focused on companies and their performanceand the Business Network - a series of interviews and profiles of some of theleading companies in biotech.
PharmaTelevision Premium Content includes PharmaTelevision News - a dailynews and analysis programme, PharmaTelevision News Review - a programmefeaturing interviews, panel discussions and analysis with leading experts andleaders in our industry and the Business Report - a programme that analyseskey business and market trends in our industry.PharmaTelevision(R) is a registered Trade Mark of PharmaVentures Ltd. For more information contact: Doug Cookson, Commercial Director, PharmaVentures Ltd +44(0)1865-332-731 [email protected]
SOURCE PharmaTelevision Ltd
